先健科技(深圳)有限公司 LifeTech Scientific Corporation
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
LifeTech Scientific Corporation Announced 2024 Interim Results: International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8% 2024-08-30 20:48
LifeTech Scientific Corporation Announced 2023 Annual Results: International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development 2024-04-02 22:13
LifeTech Scientific Corporation (1302.HK) Announces 2023 Interim Results 2023-08-30 19:39
LifeTech Reports Steady Growth of 32.5percent in Net Profit Attributable to Owners of the Company in 2022 2023-03-29 22:21
FDA-approved Investigator-initiated Pre-market Clinical Trial of LAmbre™ Plus LAA Closure System Obtained Medical Insurance Coverage in the US 2022-09-05 13:02
LifeTech Scientific Corporation (1302.HK) Announces 2022 Interim Results 2022-08-30 21:45
LifeTech Scientific Corporation(1302.HK) Announces 2021 Annual Results 2022-03-31 03:27
LifeTech and Medtronic Further Strategic Collaboration to Open New Chapter of Domestically-Made MRI-Conditional Pacemakers 2021-12-16 12:41
LifeTech Scientific Corporation Announces 2021 Interim Results 2021-08-31 03:46
LifeTech announced the launch of its global post-market surveillance study for LAmbre (TM) LAA Closure System 2017-07-03 18:59
LifeTech Announces CE Mark for LAmbre(TM) LAA Closure System 2016-06-16 13:18
1